drugset / Trial / NCT06177249
To Evaluate the Immunogenicity and Safety of Two Different Immunization Schedules of Rabies Vaccine (Vero Cell)
Phase 3
Completed
1956 enrolled
Hualan Biological Bacterin Co. Ltd.
Henan Center for Disease Control and Prevention · collab
RandomizedParallel-groupQuadruple-blindHealth-services research
Summary
To evaluate the safety and immunogenicity of lyophilized human rabies vaccine (Vero cell) developed by Hualan Biological in healthy people aged 9 to 65 years with two different immunization schedules.
Timeline
- Start
- 2015-03-15
- Primary completion
- 2015-12-16
- Completion
- 2016-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Rabies Vaccine（vero Cell) | Vaccine | — | — |